WELLGENETICS
Financiado
Disruptive tracer technology based on synthetic DNA to map subterranean resource...
Well Genetics was founded in 2012 in Norway by a joint team of pioneers in the use of DNA as industrial tracer and specialists with over 25 year’s track of record in monitoring of underground reservoirs. Well Genetics’ DNA tracers...
Well Genetics was founded in 2012 in Norway by a joint team of pioneers in the use of DNA as industrial tracer and specialists with over 25 year’s track of record in monitoring of underground reservoirs. Well Genetics’ DNA tracers are composed of synthetic DNA sequences encapsulated within polymer coatings. These tracers travel along underground reservoirs and fractures and enable operators to map subsurface water and oil flows. With our tracers, we mimic nature’s craftiness to store information. We can deliver billions of unique DNA tracer combinations with a detection limit that is thousands of times less than for currently used tracers, at a 50% cost reduction of an average tracer job.
Given that in underground environments, information is key to trigger millionaire investments, our DNA tracers represent a strategic value for the exploration and production of oil and geothermal energy industries, with potential benefits for our customers in the million euros range.
Moreover, we contribute to the sustainability of the energy mix. The understanding of underground flows enables more sustainable oil extraction avoiding additional wells and, makes renewable geothermal energy production feasible in locations other than limited volcanic areas. In fact, the future of geothermal energy lies in take advantage of the heat stored in the subterranean rock layers of the Earth, the information conveyed by our DNA tracers critical to tap into this clean, cheap, constant and abundant renewable energy source.
Third parties have tested the DNA tracers to ensure they are resilient enough to withstand high temperatures and conditions of reservoirs and we have received high interest from the industry. Now, successful commercialization requires demonstrated field results. Through the feasibility study phase, we will establish the conditions of the first field trial, that will trigger sales of the product.
ver más
Duración del proyecto: 3 meses
Fecha Inicio: 2018-05-07
Fecha Fin: 2018-08-31
Fecha Fin: 2018-08-31
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2018-08-31
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
EIC-SMEInst-2018-2020:
SME instrument
Cerrada
hace 6 años
Presupuesto
El presupuesto total del proyecto asciende a
71K€
Líder del proyecto
WELL GENETICS AS
No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico
TRL
4-5
Perfil tecnológico
TRL
4-5
417.49K€ |
Participante